Improving diabetes and vision care in Bangladesh
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you have diabetes.
- You have diabetic retinopathy (damage to the retina from diabetes) in at least one eye.
- You are over 30 years old.
- You receive care at Dinajpur Diabetes Hospital or Gausul Azam BNSB Eye Hospital in Bangladesh.
- You are willing to take part in the study and can have your eyes photographed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
This study tests a new camera software to help general practitioners check for diabetic retinopathy, an eye problem caused by diabetes. It is for people with type 1 or 2 diabetes who are 40 or older.
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
This study looks at how common diabetic retinopathy is and what factors increase the risk. It may help find better ways to prevent vision loss in people with diabetes.
This study looks at how fat and sugar levels in the blood relate to different stages of eye damage in people with type 2 diabetes. It may help find new ways to treat or prevent vision loss.
This trial is testing an automated tool that helps screen for diabetic retinopathy, a complication of diabetes that affects the eyes. The goal is to see if the tool can accurately detect the condition, which may help with early treatment and prevent vision loss.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.